NHRC Accepts Plea from Clinical Trial Subject Who Suffered Heart Attack

Haydarabad: Dipankar Dey, a clinical research participant who claims to be negligent after having a heart attack in Hyderabad, reached the National Human Rights Commission and sponsors in search of damage and action against the Convention Research Organization (CRO), which carried out the case and producing the drug tested in human subjects.

According to Rama Rao Immaneni, who filled the petition with NHRC on behalf of NHRC, Cro, a company based in Haydarabad, who carries out the attempt to be a participant from the Commission, is a Jeevan Scientific Technology Ltd. and Dr Redy’s Labs was asked to manage the anti-reign of 1, a sponsor of paying a payment, a sponsor. Crore for wage, injury and pain loss.

The petition said that Dey, a worker, voluntarily voluntarily on the hearing by an agent. Rama Rao, Dey’in breast cancer drug is applied, he said. After having a heart attack, “The Ethics Committee began to force the victim to sign a full treatment with Cro & sponsor, and as the victim rejected, the ethics committee was deliberately separated from informing the drug controller of India’s drug controller.”

The petition called DCGI that “DR RAINT LABS and JEEVAN Scientific Technology can be referred to the immediate cancellation of licenses given to LTD and that they can be directed to both companies to withdraw their licenses to both companies.

In addition, the petition sought a direction to the Police Chief to take the necessary measures in the two companies to deceive the innocent victims of clinical research by using the illiterate and financial conditions.